Advertisement

The Latest

Workplace stress is no longer episodic — it’s constant. Across industries, organizations are managing a workforce under continuous strain, driven by rising behavioral health needs, operational complexity, and persistent pressure to do more with less. As a result, leaders are…

While HIV prevention continues to be a public health priority, it has often been siloed in specialty settings and inconsistently measured from a quality lens. Health systems that have embedded pre-exposure prophylaxis (PrEP) into primary care are seeing a different…

Jul 7, 2026 12:00 PM - 1:00 PM CDT

Presented by:

Presented by
Presenters:
  • Mitchell Caponi, MPH
  • Indira Brar, MD, FIDSA
  • Patrick Cahill, MD
  • Crystal Curtis

Nebraska added an estimated 1.2 million behavioral health appointments in 2024 compared to 2010 as the state expanded its licensed behavioral health workforce, according to a 2026 report from the Behavioral Health Education Center of Nebraska.  The Behavioral Health Workforce…

Maryland’s five adult psychiatric hospitals are operating at an average capacity of 95%, creating monthslong wait times for some court-ordered patients, The Daily Record reported May 26.  The psychiatric hospitals “primarily serve individuals with mental illnesses who are involved in…

As health systems navigate 2026, leaders are balancing near-term performance with longer-term positioning. Shifts in care delivery, workforce dynamics, policy, and competition are reshaping where growth opportunities exist and where new constraints are emerging. We’ve created a set of ready-to-use…

Presented by:

Presented by

Like many health systems, Erlanger faced operational challenges that capped surgical growth: 30% of OR block time went unused, non-robotic cases occupied robotic rooms, independent surgeons were taking cases to competitors and scheduling was a manual, cumbersome process. Traditional scheduling…

Jun 25, 2026 12:00 PM - 1:00 PM CDT

Presented by:

Presented by
Presenters:
  • Misti Mattox, MSN, RN, CNOR
  • David Atashroo, MD

The Food and Drug Administration granted de novo approval to Modius Spero, marking it the world’s first neuromodulation device authorized to treat symptoms associated with post-traumatic stress disorder.  The wearable device was developed by Neurovalens and uses low-level electrical stimulation…

The Department of Veterans Affairs is launching a clinical trial evaluating methylenedioxymethamphetamine-assisted therapy, or MDMA-assisted therapy, for veterans with post-traumatic stress disorder and alcohol use disorder.  The trial will enroll approximately 80 veterans, comparing outcomes between participants receiving MDMA-assisted therapy…

Advertisement